Thrombocytemia and abnormal megakaryopoiesis associated with abnormality of chromosome 1p34 in myelodysplastic syndromes

Leukemia

Volumn 10, Issue 11, 1996, Pages 1692-1695

  Jondeau, K ^a   Bouscary, D ^a   Viguie F ^b   Picard, F ^a   Melle, J ^a   Lopez, I ^a   Fontenay Roupie, M ^a   Dreyfus, F ^a  

^a Hôpital Cochin ^*  (France)

^b HÔTEL DIEU   (France)

Author keywords

c mpl; Karyotype; Megakaryopoiesis; Myelodysplasia; Thrombocytemia; TPO

Indexed keywords

ARTICLE; CHROMOSOME 1P; KARYOTYPE; MEGAKARYOPOIESIS; MYELODYSPLASIA; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; STEM CELL; THROMBOCYTE COUNT; THROMBOCYTHEMIA;

EID: 0029842534     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Vanden Berghe H, Cassiman J, David C, Fryns J, Michaux J, Sokal G. Distinct haematological disorder with deletion of long arm of No. 5 chromosome. Nature 1974; 251: 437-438.
2. Lee E, Schiffer C, Tomiyasu T, Testa J. Clinical and cytogenetic correlations of abnormal megacaryocytopoiesis in patients with acute leukemia and chronic myelogenous leukemia in blast crisis. Leukemia 1990; 4: 350-353.
3. Yunis J, Rydell R, Oken M, Arnesen M, Mayer M, Lobell M. Refined chromosome analysis as an independent prognostic indicator in de novo myelodysplastic syndromes. Blood 1986; 62: 1721-1730.
4. Yunis J, Lobell M, Arnesen M, Oken M, Mayer M, Rydell R, Brunning R. Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemia. Br J Haematol 1988; 68: 189-194.
5. Anderson R, Bagby GJ. The prognostic value of chromosome studies in patients with the preleukemic syndrome (hemopoietic dysplasia). Leuk Res 1982; 6: 175-181.
6. Jotterand-Bellomo M, Parlier V, Mühlematter D, Grob J, Beris P. Three new cases of chromosome 3 rearrangement in bands q21 and q26 with abnormal thrombopoiesis bring further evidence to the existence of a 3q21q26 syndrome. Cancer Genet Cytogenet 1992; 59: 138-160.
7. Horsman D, Gascoyne R, Barnett M. Acute leukemia with structural rearrangements of chromosome 3. Leuk Lymphoma 1995; 16: 369-377.
8. Seeker-Walker L, Mehta A, Bain B. Abnormalities of 3q21 and 3q26 in myeloid malignancies: a United Kingdom Cancer Cytogenetic Group study. Br J Haematol 1995; 91: 490-501.
9. Fichelson S, Dreyfus F, Berger R, Melle J, Bastard C, Miclea J, Gisselbrecht S. Evi-1 expression in leukemic patients with rearrangement of the 3q25-q28 chromosomal region. Leukemia 1991; 6: 93-99.
10. Rubin C, Larson R, Anastasi J, Winter J, Thangavelu M, Vardiman J, Rowley J, Le Beau M. t(3;21)(q26;q22): a recurring chromosomal abnormality in therapy-related myelodysplastic syndrome and acute myeloid leukemia. Blood 1990; 76: 2594-2598.
11. Nimer S, Golde D. The 5q- abnormality. Blood 1987; 70: 1705-1712.
12. Bouscary D, Fontenay-Roupie M, Chrétien S, Hardy A-C, Viguié F, Picard F, Melle J, Dreyfus F. Thrombopoietin is not responsible for the thrombocytosis observed in patients with acute myeloid leukemia and the 3q21q26 syndrome. Br J Haematol 1995; 91: 423-427.
13. Kaushansky K, Lok S, Holly R, Broudy V, Lin N, Bailey M, Forstrom J, Buddle M, Oort P, Hagen F, Roth G, Papayannopoulou T, Foster D. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature 1994; 369: 568-571.
14. Vigon I, Mornon J, Cocault L, Mitjavila M, Tambourin P, Gisselbrecht S, Souyri M. Molecular cloning and characterization of Mpl, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor super-family. Proc Natl Acad Sci USA 1992; 89: 5640-5644.
15. Bouscary D, Preudhomme C, Ribrag V, Melle J, Viguié F, Picard F, Guesnu M, Fenaux P, Gisselbrecht S, Dreyfus F. Prognostic value of c-mpl expression in myelodysplastic syndromes. Leukemia 1995; 9: 783-788.
16. ISCN (1995). Guidelines for cancer cytogenetics. In: Mitelman F (ed). Supplement to an International System for Human Cytogenetic Nomenclature. Karger: Basel, 1995.
17. Bennett J, Catovsky D, Daniel M, Flandrin G, Galton D, Gralnick H, Sultan C. The French-American-British (FAB) Co-operative group: proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51: 189-199.
18. Sokal G, Michaux J, Van den Berghe H et al. A new hematologic syndrome with a distinct karyotype: the 5q- chromosome. Blood 1975; 46: 519-533.
19. Van den Berghe H. The 5q- syndrome. Scand J Haematol 1986; 36: 78-81.
20. Russell M, List A, Greenberg P, Woodward S, Glinsmann B, Parganas E, Ihle J, Taetle R. Expression of EVI1 in myelodysplastic syndromes and other haematologic malignancies without 3q26 translocations. Blood 1994; 84: 1243-1248.
21. Gigg A, Gascoyne R, Philips G, Horsman D. Clinical, haematological and cytogenetic features in 24 patients with structural rearrangements of the Q arm of chromosome 3. Br J Haematol 1993; 83: 158-165.